A woman who was given two months to live said she told her cancer to “go away” and refused to die. before doctors told him the leukemia was in remission. The extraordinary case was published by the British newspaper Mirror and is based on the testimony of the woman, who assures that she was cured of the serious illness after undergoing experimental treatment.
Eliana Keeling, 65, began chemotherapy on Christmas Day 2020, just a week after a routine blood test revealed that she had AML.
Intrigued by the shock, fit and active Eliana refused to accept it was the end when doctors told her five months later that the treatment had not worked and that she was dying.
The retired teacher asked to be referred to a cancer expert center, The Christie, in Manchester, e was enrolled in a clinical drug trial that brought her into remission in just six months.
Upon learning that she did not have cancer, Eliana began to cry.
He told the British newspaper Mirror: “I was talking to my cancer, it seems strange but I would tell him ‘I’m not happy’ and that I would fight for my life. blood.'”
“I burst into tears when they told me he was gone, I couldn’t believe it, it seemed like a miracle.”
In June 2021 Eliana was invited to participate in the initial phase of an international trial of a new investigational drug used in combination with the azacitidinewhich is already used to treat patients with leukemia.
The theory behind the study is that the experimental drug, in pill form, makes the conventional drug, given by injection, work more effectively.
In December last year, Eliana’s body was free from cancer, which allowed him to undergo a bone marrow transplant, which means he’s been in remission ever since.
Last month she celebrated her 31st wedding anniversary with her husband, John, and said there are many more things on her wish list that she would like to complete.
For her part, Dr Emma Searle, consultant hematologist at The Christie, commented, “She had a poor prognosis and her only option was clinical trial and bone marrow transplant for long-term survival. We are very happy that he had such a good response and that he is now free of leukemia. Given that she had a very limited life expectancy when chemotherapy failed, this is an excellent result for her. “
Likewise, she clarified that not all patients participating in the study get the same response as Eliana. However, she stressed: “We are grateful to all patients and family members who feel able to support the investigation. All of this is very important for advancing cancer treatment ”.
Acute myeloid leukemia is estimated to affect around one in 200 men and one in 255 women in the UK.
Source: Clarin
